🟢 Biomea Fusion is trading 5.63% up today amid broader biotech strength

Biomea Fusion is trading at $0.66, up 5.63%, with biotech-sector strength a possible factor.

• The biotech ETF XBI was reported up 2.13%, alongside a broader rotation into biotech stocks.
• No confirmed Biomea Fusion announcement explaining the November 4 move appeared in the available company-news search; the latest company press release located was October 13.
• Available information points to sector context, not a confirmed company-specific catalyst; volume details were not provided.